Delivery Order SPE2DB20D7059-SPE2DB25FQDJ5

Award Date 4/2/25
Potential Completion Date 4/23/25
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $1,396.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, provides for the procurement of XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of February 6, 2025 and uses a firm-fixed-price pricing type. The award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $23,467.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, with an ultimate completion date of April 14, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $13,559.00, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order for the provision of 4,566,773,316 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a firm fixed-price pricing type and an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 100 unit vials. The $46,934.16 fixed-price contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has a performance period ending on July 17, 2025. The award is not set aside and indicates open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,396.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XEOMIN 100 UNIT VIALS, with an ultimate completion date of June 26, 2025. The contract is not set aside and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,242.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 200 unit vials, a pharmaceutical product, with a completion date of May 19, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $3,145.44, has an ultimate completion date of August 13, 2024. As an Indefinite Delivery Contract (IDC) vehicle with a ceiling of up to $999,999,999 through December 2025, this award supports the DLA's efforts to provide a comprehensive range of medical...
This federal contract award, valued at $20,114.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,110,066 units of XEOMIN 200 unit vials, with a completion date of May 22, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,179.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,738,226 units of XEOMIN 50 unit vials. The contract is a Firm Fixed Price Delivery Order that runs through January 7, 2025. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,727.50 firm fixed-price delivery order is for the supply of XEOMIN 200 unit vials. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQDJ5
    Delivery Order

This federal contract award, valued at $46,934.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, identified as SPE2DB20D7059|SPE2DB25FQDJ5, is for the delivery of XEOMIN 100 UNIT VIALS and has an ultimate completion date of April 23, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/2/25, 10:43 PM